Results 31 to 40 of about 119,690 (213)

Lipoprotein(a) in children and adolescents with genetically confirmed familial hypercholesterolemia followed up at a specialized lipid clinic

open access: yesAtherosclerosis Plus
Background and aim: Many children with an FH mutation also exhibit elevated lipoprotein(a) levels, which is an independent risk factor for atherosclerotic cardiovascular disease.
Anja K. Johansen   +8 more
doaj   +1 more source

The Effect of Hypercholesterolemia on Cortical Bone Thickness of Wistar Rats (Rattus norvegicus)

open access: yesFolia Medica Indonesiana, 2021
There have been several studies reporting the effect of hypercholesterolemia on cortical thickness, but it remains a controversy. Some studies suggest that hypercholesterolemia can decrease osteoblast activity and increase osteoclast activity.
Auliya Dzaqiyatus Sofka   +2 more
doaj   +1 more source

Managing hypercholesterolemia and its correlation with carotid plaque morphology in patients undergoing crotid endarterectomy

open access: yes, 2008
Purpose: hypercholesterolemia is a critical problem in patients with carotid atherosclerosis. The adequacy of attention to lipid risk factors in patients with carotid stenosis awaiting carotid endarterectomy (CEA) has rarely been studied.
Clifford P Shearman   +9 more
core   +1 more source

Renal Expression of Monocyte Chemoattractant Protein-1 in Low-Density Lipoprotein Receptor Knockout Mice with Diet-Induced Hypercholesterolemia [PDF]

open access: yes, 1999
Abnormalities in lipid metabolism appear to play a pivotal role in progressive renal diseases.Monocyte chemoattractant protein (MCP)-1 plays pivotal roles in several inflammatory conditions including renal damage in diabetes.However,the pathogenesis of ...
林, 晋一郎   +3 more
core  

Immune Modulatory Effects of Hypercholesterolemia: Can Atorvastatin Convert the Detrimental Effect of Hypercholesterolemia on the Immune System?

open access: yesIranian Journal of Allergy, Asthma and Immunology, 2019
Many observations showed that hypercholesterolemia can disrupt immune response. Statin drugs that were used for the treatment of hypercholesterolemia patients can interfere in the regulation of the immune response and cytokine secretion.
Zeinab Emruzi   +4 more
doaj   +1 more source

Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.

open access: yesPLoS ONE, 2017
Hypercholesterolemia is a known contributor to the pathogenesis of Alzheimer's disease while its role in the occurrence of Parkinson's disease (PD) is only conjecture and far from conclusive.
Rajib Paul   +5 more
doaj   +1 more source

Ocular manifestations of severe familial hypercholesterolemia

open access: yesHeliyon
Background: To study ocular manifestations of patients with severe familial hypercholesterolemia (FH). Methods: In this population-based case-control study, patients suffering from severe familial hypercholesterolemia from the Lebanese Familial ...
Alaa Bou Ghannam   +5 more
doaj   +1 more source

Relationship Of Waist Circumference And Hypercholesterolemia Incidence In Patient With Hypertension in Tegal Gundil Public Health Center at Bogor City

open access: yesJurnal Kesehatan Komunitas (Journal of Community Health), 2019
Hypertension and hypercholesterolemia are the causes of coronary heart disease (CHD) so that the presence of hypercholesterolemia in patients with hypertension will increase the risk of CHD.
Siti Hana, Ratu Ayu Dewi Sartika
doaj   +1 more source

Patient with homozygous familial hypercholesterolemia: difficult to treat. Case report

open access: yes, 2020
Homozygous familial hypercholesterolemia is a severe genetic disorder characterized by extremely high levels of total cholesterol and low-density lipoprotein cholesterol (LDL-C), as well as by rapid atherosclerosis progression in various vascular ...
Andrey V. Susekov   +5 more
core   +1 more source

Epidemiology of hypercholesterolemia [PDF]

open access: yesVnitřní lékařství, 2018
Hypercholesterolemia is one of the most important risk factors of cardiovascular (CV) disease. Epidemiology follows the prevalence, the incidence and the possibilities of risk factors or diseases intervention. A review of observation epidemiologic studies, pharmacotherapy and treatment perspectives is presented.
Barbora, Nussbaumerová, Hana, Rosolová
openaire   +2 more sources

Home - About - Disclaimer - Privacy